|
|
STING-Activating GM-CSF Secreting Allogeneic Pancreas Tumor Cell Vaccine Therapy
|
1R43CA186424-01
|
$224,878
|
$224,878
|
DUBENSKY, THOMAS
|
ADURO BIOTECH
|
|
|
Core Support for Cancer Center
|
3P30CA013330-41S1
|
$75,000
|
$3,000
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
3P30CA013330-41S2
|
$148,500
|
$5,940
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Core Support for Cancer Center
|
5P30CA013330-41
|
$3,585,248
|
$143,410
|
GOLDMAN, ISRAEL
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Deciphering the Tissue Specificity of MEN1 Related Tumorigenesis
|
5R01CA170911-03
|
$336,129
|
$168,065
|
LIBUTTI, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
|
1F31CA183493-01A1
|
$47,676
|
$23,838
|
OHAEGBULAM, KIM
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
Interactions of the angiopoietin and PD-ECGF pathways in tumor angiogenesis
|
5R01CA163907-03
|
$336,129
|
$336,129
|
SCHWARTZ, EDWARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
1R01CA175495-01A1
|
$346,525
|
$86,631
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
The B7x pathway in the tumor microenvironment
|
3R01CA175495-01A1S1
|
$59,075
|
$14,769
|
ZANG, XINGXING
|
ALBERT EINSTEIN COLLEGE OF MEDICINE
|
|
|
RTOG Biospecimen Repository
|
3U24CA114734-08S1
|
$946,151
|
$94,615
|
CURRAN, WALTER
|
AMERICAN COLLEGE OF RADIOLOGY
|
|
|
Pancreatic-Cancer Imageable Patient-Derived Orthotopic Xenografts (iPDOX)
|
1R43CA183280-01A1
|
$224,700
|
$224,700
|
YANG, MENG
|
ANTICANCER, INC.
|
|
|
Enhancing T Cell Therapy of Cancer
|
5P01CA094237-12
|
$1,874,319
|
$468,580
|
HESLOP, HELEN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Advanced Glycation End-Products and Risk of Pancreatic Cancer
|
5R01CA172880-02
|
$620,623
|
$620,623
|
JIAO, LI
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Chimeric Antigen Receptor Modified T Cell Therapy for Pancreatic Cancer
|
1F32CA189423-01
|
$55,094
|
$55,094
|
MOHAMMED, SOMALA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S1
|
$75,000
|
$3,750
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S3
|
$48,834
|
$2,442
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-08S4
|
$149,801
|
$7,490
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-08
|
$2,746,741
|
$137,337
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
The MB-CCOP at Boston Medical Center
|
3U10CA139519-03S5
|
$110,177
|
$1,102
|
KACHNIC, LISA
|
BOSTON MEDICAL CENTER
|
|
|
Non-Oncogene Addiction as a Targeted Therapy for Pancreatic Cancer
|
5R21CA164245-02
|
$197,693
|
$197,693
|
FALLER, DOUGLAS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Defining lineage-specific determinants of K-Ras ""addiction"" in human cancers
|
5R00CA149169-05
|
$231,443
|
$76,376
|
SINGH, ANURAG
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
1U10CA180821-01
|
$10,540,919
|
$527,046
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S1
|
$228,063
|
$11,403
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S2
|
$264,661
|
$13,233
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-01S3
|
$16,838
|
$842
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Support for Specimen Banking in ACOSOG
|
3U24CA114736-08S1
|
$395,137
|
$79,027
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
|
Microbiomes in Human Pancreatic Cancer
|
5R01CA166150-02
|
$701,967
|
$701,967
|
MICHAUD, DOMINIQUE
|
BROWN UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S1
|
$74,051
|
$1,481
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S2
|
$29,166
|
$583
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-24S3
|
$145,188
|
$2,904
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Case Comprehensive Cancer Center Support Grant
|
5P30CA043703-24
|
$4,748,649
|
$94,973
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
A RAS-FAM83A Regulatory Loop as a Novel Therapeutic Target for Pancreatic Cancer
|
5R21CA178651-02
|
$167,198
|
$167,198
|
JACKSON, MARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
CWRU Case Comprehensive Cancer Center NCTN Lead Academic Participating Site
|
1U10CA180853-01
|
$1,188,450
|
$29,711
|
MACHTAY, MITCHELL
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Targeting Telomerase in Pancreateic Cancer
|
5R21CA169611-02
|
$163,276
|
$163,276
|
TAYLOR, DEREK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Next-generation mouse gene-targeting technology to model tumorigenesis
|
5R21CA181859-02
|
$234,077
|
$77,245
|
WANG, ZHENGHE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
|
Improving Pancreas RT Plans using Respiration-driven Anatomic Deformation
|
5R03CA173273-02
|
$77,661
|
$77,661
|
YANG, WENSHA
|
CEDARS-SINAI MEDICAL CENTER
|
|
|
FrostBite - A Unique Catheter for Endoscopic Cryoablation
|
1R43CA183265-01
|
$225,000
|
$225,000
|
BAUST, J
|
CELL PRESERVATION SERVICES, INC.
|
|
|
Novel Small Molecule Therapeutics for Pancreatic Cancer
|
1R41CA176931-01A1
|
$240,555
|
$240,555
|
OKOLOTOWICZ, KARL
|
CHEMREGEN, INC.
|
|
|
IDO-silencing Salmonella therapy for the treatment of primary and metastatic PDAC
|
5R21CA174306-02
|
$212,663
|
$212,663
|
DIAMOND, DON
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S1
|
$121,881
|
$1,219
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S2
|
$64,080
|
$641
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S3
|
$126,241
|
$1,262
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
3P30CA033572-31S4
|
$12,600
|
$126
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Cancer Center Support Grant
|
5P30CA033572-31
|
$2,119,061
|
$21,191
|
ROSEN, STEVEN
|
CITY OF HOPE/BECKMAN RESEARCH INSTITUTE
|
|
|
Development of Monoclonal Antibodies To Treat Pancreatic Cancer
|
3R43CA174025-01A1S1
|
$146,053
|
$146,053
|
PANTAZIS, PANAYOTIS
|
COARE BIOTECHNOLOGY, INC.
|
|
|
Cold Spring Harbor Laboratory Cancer Research Center
|
5P01CA013106-43
|
$4,221,622
|
$211,081
|
HANNON, GREGORY
|
COLD SPRING HARBOR LABORATORY
|
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
3P30CA045508-27S1
|
$384,000
|
$34,560
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
|
CSHL CANCER CENTER SUPPORT GRANT
|
5P30CA045508-27
|
$4,224,416
|
$380,197
|
STILLMAN, BRUCE
|
COLD SPRING HARBOR LABORATORY
|
|
|
(PQA-4) Organoid Omics To Detect And Defeat Ductal Pancreatic Cancer
|
1R01CA190092-01
|
$555,711
|
$555,711
|
TUVESON, DAVID
|
COLD SPRING HARBOR LABORATORY
|
|
|
Chemical genetic profiling of engineered tumor cells
|
5R01CA097061-11
|
$339,671
|
$339,671
|
STOCKWELL, BRENT
|
COLUMBIA UNIV NEW YORK MORNINGSIDE
|
|
Total relevant funding to Pancreas for this search: $122,362,386
|
